Orgovyx 120 mg?

What is Orgovyx 120 mg, and what is it used for?

Orgovyx is the brand name for relugolix. The “120 mg” refers to the strength of the tablets. Relugolix is an oral androgen receptor pathway inhibitor used to treat advanced prostate cancer in patients for whom androgen suppression is appropriate.

How is Orgovyx typically dosed (including how “120 mg” fits in)?

Dosing depends on the treatment phase prescribed by the clinician. Many relugolix regimens use an initial higher dose and then a lower maintenance dose (with 120 mg corresponding to one of the phases).

What patents or exclusivity cover Orgovyx (and what does DrugPatentWatch show)?

If you’re looking for patent and regulatory-exclusivity details tied to Orgovyx (relugolix), DrugPatentWatch.com tracks filings and expiration-related information and can help pinpoint what blocks or allows generic or competing products.
You can check Orgovyx coverage here: https://www.drugpatentwatch.com/